BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Diagnosis
22 results:

  • 1. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
    Li J; Qi C; Li Q; Liu F
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Chaperone System in breast cancer: Roles and Therapeutic Prospects of the Molecular Chaperones Hsp27, Hsp60, Hsp70, and hsp90.
    Alberti G; Vergilio G; Paladino L; Barone R; Cappello F; Conway de Macario E; Macario AJL; Bucchieri F; Rappa F
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887137
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma.
    Yao ZP; Zhu H; Shen F; Gong D
    Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):380-390. PubMed ID: 34767669
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long non-coding RNA NKILA regulates expression of hsp90α, NF-κB and β-catenin proteins in the MCF-7 breast cancer cell line.
    Tibatan MA; Önay Uçar E
    Mol Biol Rep; 2021 May; 48(5):4563-4571. PubMed ID: 34125329
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular Chaperones in Osteosarcoma: diagnosis and Therapeutic Issues.
    Lallier M; Marchandet L; Moukengue B; Charrier C; Baud'huin M; Verrecchia F; Ory B; Lamoureux F
    Cells; 2021 Mar; 10(4):. PubMed ID: 33808130
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-hsp90 gene construct to combat colon cancer.
    Jinka S; Rachamalla HK; Bhattacharyya T; Sridharan K; Sekhar Jaggarapu MMC; Yakati V; Banerjee R
    Biomed Mater; 2021 Feb; 16(2):024105. PubMed ID: 33434900
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
    Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
    Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer.
    Crouch BT; Gallagher J; Wang R; Duer J; Hall A; Soo MS; Hughes P; Haystead T; Ramanujam N
    Sci Rep; 2019 Mar; 9(1):3461. PubMed ID: 30837677
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Prognostic Significance of Hsp70/hsp90 Expression in breast cancer: A Systematic Review and Meta-analysis.
    Dimas DT; Perlepe CD; Sergentanis TN; Misitzis I; Kontzoglou K; Patsouris E; Kouraklis G; Psaltopoulou T; Nonni A
    Anticancer Res; 2018 Mar; 38(3):1551-1562. PubMed ID: 29491085
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Leveraging ectopic hsp90 expression to assay the presence of tumor cells and aggressive tumor phenotypes in breast specimens.
    Crouch B; Murphy H; Belonwu S; Martinez A; Gallagher J; Hall A; Soo MS; Lee M; Hughes P; Haystead T; Ramanujam N
    Sci Rep; 2017 Dec; 7(1):17487. PubMed ID: 29235516
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in cancer.
    Saini J; Sharma PK
    Curr Drug Targets; 2018; 19(13):1478-1490. PubMed ID: 28831912
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A Fluorescent hsp90 Probe Demonstrates the Unique Association between Extracellular hsp90 and Malignancy in Vivo.
    Crowe LB; Hughes PF; Alcorta DA; Osada T; Smith AP; Totzke J; Loiselle DR; Lutz ID; Gargesha M; Roy D; Roques J; Darr D; Lyerly HK; Spector NL; Haystead TAJ
    ACS Chem Biol; 2017 Apr; 12(4):1047-1055. PubMed ID: 28103010
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.
    Kazarian A; Blyuss O; Metodieva G; Gentry-Maharaj A; Ryan A; Kiseleva EM; Prytomanova OM; Jacobs IJ; Widschwendter M; Menon U; Timms JF
    Br J Cancer; 2017 Feb; 116(4):501-508. PubMed ID: 28081538
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery.
    Grubb CS; Jani A; Wu CC; Saad S; Qureshi YH; Nanda T; Yaeh A; Rozenblat T; Sisti MB; Bruce JN; McKhann GM; Sheth SA; Lesser J; Cheng SK; Isaacson SR; Lassman AB; Connolly EP; Wang TJ
    J Neurooncol; 2016 Mar; 127(1):103-10. PubMed ID: 26615564
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
    Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
    Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Serum levels of hsp90 in the continuum of breast ductal and lobular lesions.
    Zagouri F; Sergentanis TN; Provatopoulou X; Kalogera E; Chrysikos D; Lymperi M; Papadimitriou CA; Zografos E; Bletsa G; Kalles VS; Zografos GC; Gounaris A
    In Vivo; 2011; 25(4):669-72. PubMed ID: 21709012
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes.
    Mojtahedi Z; Safaei A; Yousefi Z; Ghaderi A
    OMICS; 2011 Jun; 15(6):409-18. PubMed ID: 21568730
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL.
    McKeen HD; Brennan DJ; Hegarty S; Lanigan F; Jirstrom K; Byrne C; Yakkundi A; McCarthy HO; Gallagher WM; Robson T
    Biochem Soc Trans; 2011 Apr; 39(2):663-8. PubMed ID: 21428958
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer.
    Sun B; Zhang S; Zhang D; Li Y; Zhao X; Luo Y; Guo Y
    Clin Cancer Res; 2008 Nov; 14(21):7050-9. PubMed ID: 18981002
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Advances in the diagnosis of unknown primary carcinoma of the neck].
    Kruk-Zagajewska A; Milecki P; Wierzbicka M
    Otolaryngol Pol; 2005; 59(1):77-83. PubMed ID: 15915923
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.